TCL Archive NBCC Sees $2.6 billion for Breast Cancer By Year 2000, Begins Voter Registration Drive May 10, 1996
TCL Archive NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC April 30, 2010
TCL Archive GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer. November 2, 2007
TCL Archive FDA To Tighten Up Regulations On Anticancer Drug Combinations, Stop “Permissiveness” September 3, 1976
TCL Archive US Could Lose Leadership In Research If NIH Budget Is Cut, ASCO President Says June 2, 1995
